Create issue ticket

9,780 Possible Causes for cellular, chronic, diagnosis,, Leukemia, myelogenous

  • Chronic Myeloid Leukemia

    It is important that treatment is started as early as possible, preferably right after a confirmed diagnosis since it is difficult to treat CML in its more advanced stages[] What are the symptoms of chronic myeloid leukemia? Chronic myeloid leukemia has three phases: chronic, accelerated, and blastic.[] The action of the BCR-ABL protein is the pathophysiologic cause of chronic myelogenous leukemia.[] Constitutive activation of NFκB and β-catenin signaling promotes cellular proliferation and survival and resistance to Imatinib therapy in CML.[] The presence of ACA at diagnosis does not confer worse prognosis for patients with CML treated with TKI.[]

  • Lymphoblastic Lymphoma

    T-LBL) is a rare lymphoma presenting clinically in children and adolescents with a rapidly enlarging mediastinal mass, dyspnea, and cervical lymphadenopathy requiring quick diagnosis[] Abstract A 14-year-old boy presented with chronic myelogenous leukemia (CML) in blast phase with segregated extramedullary (nodal) myeloid sarcoma and T-lymphoblastic lymphoma[] OBJECTIVES: This session of the 2013 Society of Hematopathology/European Association for Haematopathology Workshop was dedicated to B-acute lymphoblastic leukemia (B-ALL)[] Allogeneic hematopoietic stem cell transplantation (allo-HSCT) requires long-term immunosuppressive therapy, while cellular immunity is usually compromised due to intensive[] To establish the diagnosis definitively, a right craniotomy and open, frameless stereotactic biopsy were performed, which yielded the diagnosis of lymphoblastic T cell lymphoma[]

  • Calcium Carbonate

    The diagnosis of milk-alkali syndrome is made almost entirely based on the patient's history; careful attention to dietary practices and over-the-counter drug use is required[] BACKGROUND: Sevelamer is an alternative to calcium carbonate for the treatment of hyperphosphatemia among non-dialysis dependent patients with chronic kidney disease (CKD)[] PURPOSE: Imatinib mesylate (Gleevec( )/Glivec( )) has revolutionized the treatment of chronic myeloid leukemias and gastrointestinal stromal tumors, and there is evidence[] PURPOSE: Nilotinib is a second-generation oral tyrosine kinase inhibitor with superior efficacy compared with imatinib mesylate in the treatment for chronic phase chronic myelogenous[] Cellular influence of CaCO₃ nanoparticles is caused by intracellular calcium release. If inhaled CaCO₃ nanoparticles have the potential to influence cellular events.[]

  • Cantharidin

    It has been cited that up to one-third of nongenital warts become recalcitrant, and biopsy is often required to confirm diagnosis and direct appropriate treatment.[] , BCR-ABL Positive/drug therapy* Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism Leukemia, Myelogenous[] DNA repair and apoptosis play a major role as determinants of cellular response to CAN.[] Abstract A patient admitted to hospital died shortly after admission without a proper diagnosis having been made.[] Twenty-nine children aged 5-10 with a diagnosis of MC were enrolled to receive treatment with cantharidin or placebo.[]

  • Anaplasma Phagocytophilum

    Abstract The article focuses on the clinical and laboratory diagnosis of human granulocytic anaplasmosis (HGA) caused by Anaplasma phagocytophilum infection in one of 28 patients[] AIMS: The occurrence of human granulocytic ehrlichiosis (HGE) in a patient with chronic myelogenous leukaemia (CML) provided an opportunity to study whether Anaplasma phagocytophilum[] […] assay, sequencing of the 16S rRNA gene, msp2 ( p44 ), and ankA genes, and staining and electron microscopy of morulae of A. phagocytophilum in cultured human promyelocytic leukemia[] The Asp14 domain that is sufficient for cellular adherence and invasion lies within the C-terminal 12 to 24 amino acids and is conserved among other Anaplasma and Ehrlichia[] BACKGROUND: The infection with Borrelia burgdorferi can result in acute to chronic Lyme disease.[]

  • Peripheral T-cell Lymphoma

    PTCL occurred 4 years after the diagnosis of MCD, and LDCHL was developed 6 years after the treatment of PTCL, sequentially.[] , BCR-ABL Positive/drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology* Lymphoma, T-Cell, Peripheral[] A splenectomy revealed T-LGL leukemia.[] We recently identified five cases of CL composed of PTCL and classical HL, mixed cellularity type. We investigated histological and clinical features of these cases.[] Familiarity with these imaging features may be helpful for the diagnosis and differential diagnosis.[]

  • Chronic Lymphocytic Leukemia

    A histopathological diagnosis of RT with concordant clinical and radiological findings was obtained in 13 patients.[] Chronic Lymphocytic Leukemia . CRC Press. p. 19. ISBN 9781420068962 . a b c d e f g h i j "Chronic Lymphocytic Leukemia Treatment" .[] […] diagnosis Leukemia, Lymphocytic, Chronic, B-Cell/pathology* Leukemia, Myeloid, Acute/diagnosis* Leukemia, Myeloid, Acute/drug therapy Leukemia, Myeloid, Acute/etiology* Leukemia[] The T-cell type has cells that express surface antigens characteristic of T cells. acute myelogenous leukemia (AML) acute leukemia of the myelogenous type, one of the two[] The results described here are the first detailed formal presentation of cellular kinetics across 2 diseases and highlight the importance of the application of in vivo cellular[]

  • Thorotrast

    The histological diagnosis was cholangiocarcinoma.[] Twenty-six years after the angiography he developed chronic lymphocytic leukemia with massive lymphadenopathy.[] Termination in blast crisis, also seen in a few other patients with chronic neutrophilic leukemia, indicates that this is indeed a form of leukemia and not a "leukemoid" reaction[] If also considering cases of acute lymphocytic leukemia (1), chronic myelogenous leukemia (3), non-Hodgkins lymphoma (4), and multiple myeloma (2), the risk estimate became[] Although the mechanism is hypothesized to be via cellular damage, DNA being a major target, wrought by the high LET alpha-particles, the specific genes and the actual sequence[]

  • Clofibrate

    The authors are reporting the case of a patient with clinical and laboratory diagnosis of X-linked-adrenoleukodystrophy.[] It is suggested that chronic renal failure should be regarded as a contraindication to the use of clofibrate for the treatment of any coexisting hyperlipidaemia.[] P388/metabolism Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy* Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism Membrane Lipids/chemistry* Mice[] .: The diagnosis and management of the hyperlipoproteinemias. In: Drug in cardiology, ed.: E. Donoso, p. 127. New York: Medical Book Corp 1975 Google Scholar 14.[] […] antihyperlipidemic agent, was employed as a drug response modulator in this study to evaluate its action, if any, on adriamycin (ADR) cytotoxicity in adriamycin insensitive chronic[]

  • Rhus Verniciflua

    With a clinical diagnosis of unresectable metastatic RCC, immunotherapy was recommended, but he refused.[] We investigated the mechanisms involved in mediating the effects of Rhus verniciflua Strokes (R. verniciflua) extract in human chronic myelogenous leukemia K562 cells, including[] KEY FINDINGS: Results showed that RVS suppressed rotenone-induced reactive oxygen species generation, cellular injury and apoptotic cell death.[] Cells exposed to rotenone for 24 h-induced cellular injury and apoptotic cell death. Pretreatment of cells with RVS provided significant protection to SH-SY5Y cells.[] The therapeutical effect of sulfuretin in leukemia is due to its potent apoptotic activity through the extrinsic pathway driven by a Fas-mediated caspase-8-dependent pathway[]

Similar symptoms